Nom du produit:6-Bromohexanoyl chloride
IUPAC Name:6-bromohexanoyl chloride
- CAS：22809-37-6
- Formule moléculaire：C6H10BrClO
- Pureté：95%+
- Numéro de catalogue：CM343221
- Poids moléculaire：213.5
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:22809-37-6
- Formule moléculaire:C6H10BrClO
- Point de fusion:-
- Code SMILES:O=C(Cl)CCCCCBr
- Densité:
- Numéro de catalogue:CM343221
- Poids moléculaire:213.5
- Point d'ébullition:
- N° Mdl:MFCD00000761
- Stockage:
Category Infos
- Aliphatic Chain Compounds
- Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.
Column Infos
- Naronapride
- FDA approved an Investigational New Drug (IND) application for Naronapride to treat PPI-non-responsive symptomatic gastroesophageal reflux disease (GERD) .
Naronapride is a potential best-in-class oral, locally acting pan-GI prokinetic, which works by modulating two validated targets on the luminal surface of the intestinal wall, 5-HT4 receptor agonism and D2 receptor antagonism, with a well-differentiated pharmaceutical, pharmacokinetics, safety, and efficacy profile from other 5-HT4 agonists.
Recherche 
+86 21 5895 0110 
